Immunotherapy can induce durable tumor regression in patients with metastatic cancer, largely driven by the immune system’s recognition of tumor-specific neoantigens. Discovery and validation of TCRs against common immunogenic neoantigens Off-the-shelf TCR cell therapy for cance... Read more